Form ARS - Annual Report to Security Holders:
SEC Accession No. 0000950170-23-014870
Filing Date
2023-04-26
Accepted
2023-04-26 16:38:01
Documents
1
Period of Report
2022-12-31
Effectiveness Date
2023-04-26

Document Format Files

Seq Description Document Type Size
1 ARS ars_-_2022_ann_rep__swis.pdf ARS 5925122
  Complete submission text file 0000950170-23-014870.txt   8162550
Mailing Address BAARERSTRASSE 14 ZUG V8 CH-6300
Business Address BAARERSTRASSE 14 ZUG V8 CH-6300 6173154600
CRISPR Therapeutics AG (Filer) CIK: 0001674416 (see all company filings)

EIN.: 473173478 | State of Incorp.: V8 | Fiscal Year End: 1231
Type: ARS | Act: 34 | File No.: 001-37923 | Film No.: 23850359
SIC: 2836 Biological Products, (No Diagnostic Substances)